C01CA04 - Dopamine |
Not porphyrinogenic |
NP |
Rationale
Endogenous substance. Non-CYP metabolism. No data pointing to CYP-interaction.
Therapeutic characteristics
Endogenous signal substance liberating noradrenaline. Used in shock due to its inotropic effect on heart minute volume.
Metabolism and pharmacokinetics
Metabolized by monoamine oxidase and COMT, primarily in the liver.
Personal communication
Stig Thunnel 2004: Used in Swedish porphyria ward.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Other sources | |
| 1. | Leitlinie zur durchführung von anästhesien bei patienten mit porphyrie. Anästhesiologie & intensivmedizin 2002;43:485-9.
Böhrer H, et al. |
|
Tradenames
Dopaminehydrochloride · Neoatricon 
Neoatricon 
Dopamina · Neoatricon 
Dopamin · Neoatricon 
Dopamina · Neoatricon 
Clorhidrat Dopamina 
Dopamin 
Dopamine · Dopamine hydrochloride · Neoatricon 
Dopmin · Neoatricon 
Abbodop · Dopamin · Dopamine · Giludop 
Dopamin 
Dopaminum · Neoatricon 
Dopamina 
DBL&trade · Dopamine · Revimine · Sterile Dopamine 
Dopamine 
Dopamin 
Neoatricon 
Dopmin · Neoatricon 
Dopamine · Neoatricon 
Neoatricon 
Dopmin · Neoatricon 
Dopamin · Neoatricon 
Dopamin 
Neoatricon · Tensamin 
Neoatricon 
Dopamina 
Dopamine